Li Xiaohui, Lu Zhaomin, Li Shuo, Zhu Lin, Jiang Teng, Sun Huiling, Pan Yuqin, Zhou Junshan, Deng Qiwen
Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Neurol Sci. 2025 Jan;46(1):285-293. doi: 10.1007/s10072-024-07751-x. Epub 2024 Sep 7.
The treatment of acute ischemic stroke (AIS) aims to achieve early vascular recanalization and reperfusion of the penumbra. However, the effect of early penumbral imaging within 6 h on clinical outcomes remains unclear. The objective of this study was to determine the effect of magnetic resonance-guided (MR-guided) perfusion imaging within 6 h after symptom onset on endovascular thrombectomy outcomes in AIS patients.
We prospectively collected the clinical information of consecutive AIS patients undergoing endovascular thrombectomy based on MR-guided perfusion imaging within 6 h after symptom onset from AISRNA and EVTRNA studies. The primary outcome was defined as the poor outcome (mRS > 2 within 90 days). The perfusion-weighted imaging/diffusion-weighted imaging (PWI/DWI) mismatch was assessed by an automated software.
We enrolled 84 patients (25 in the mismatch ≤ 1.8 group and 59 in the mismatch > 1.8 group). Significant difference was found between the mismatch > 1.8 group and the mismatch ≤ 1.8 group for the incidence of disabling stroke (mRS > 2) within 90 days (40.7% vs. 68.0%, OR: 3.099, 95% CI: 1.154-8.323, P = 0.025). Intracranial hemorrhage occurred in 8 patients (13.6%) in the mismatch > 1.8 group and 10 patients in the mismatch ≤ 1.8 group (40.0%) (P = 0.010). The risk of severe cerebral edema was 2/59 (3.4%) vs. 7/25 (28.0%) (P = 0.004). These findings remained stable after adjustment.
MR-guided perfusion imaging mismatch profiles within 6 h after symptom onset may be feasible to predictclinical outcomes and reduce clinically ineffective reperfusion after endovascular thrombectomy.
急性缺血性卒中(AIS)的治疗旨在实现早期血管再通和半暗带再灌注。然而,症状出现6小时内早期半暗带成像对临床结局的影响仍不明确。本研究的目的是确定症状发作后6小时内磁共振引导(MR引导)灌注成像对AIS患者血管内血栓切除术结局的影响。
我们前瞻性收集了AISRNA和EVTRNA研究中症状发作后6小时内基于MR引导灌注成像接受血管内血栓切除术的连续AIS患者的临床信息。主要结局定义为不良结局(90天内mRS>2)。灌注加权成像/扩散加权成像(PWI/DWI)不匹配通过自动化软件进行评估。
我们纳入了84例患者(不匹配≤1.8组25例,不匹配>1.8组59例)。90天内致残性卒中(mRS>2)的发生率在不匹配>1.8组和不匹配≤1.8组之间存在显著差异(40.7%对68.0%,OR:3.099,95%CI:1.154 - 8.323,P = 0.025)。不匹配>1.8组有8例患者(13.6%)发生颅内出血,不匹配≤1.8组有10例患者(40.0%)发生颅内出血(P = 0.010)。严重脑水肿的风险分别为2/59(3.4%)和7/25(28.0%)(P = 0.004)。调整后这些结果仍然稳定。
症状发作后6小时内MR引导的灌注成像不匹配情况可能有助于预测临床结局并减少血管内血栓切除术后临床上无效的再灌注。